Will you still need me, will you still screen me, when I'm past 64?

BMJ 1997; 315 doi: 10.1136/bmj.315.7115.1032 (Published 25 October 1997)
Cite this as: BMJ 1997;315:1032

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Breast screening policy is based on ageism

  1. Graham C Sutton, Senior clinical lecturera
  1. a Nuffield Institute for Health, Leeds LS2 9PL

    Breast screening policy in Britain is based on women's age, as it should be. Age is the most important risk factor for breast cancer, and in younger women the health gain from screening is vanishingly small. A lower age limit is therefore rational. But when age related decisions are irrational or inequitable, they may reflect ageism. Is this the case with the upper limit for breast screening?

    The NHS screening service follows the recommendation in the Forrest report that in view of poor response rates there is insufficient benefit from offering screening to women aged 65 and over, though it may be available on request.1 This recommendation was based on the Utrecht study and the United Kingdom trial,2 3 both of which apparently showed a rapid fall in acceptance of repeated screening over 65.1 In Sweden, by contrast, uptake was 80% to age 74.4 However, neither the Utrecht nor the British trial recruited women over 65. Forrest presumably meant the Nijmegen study, where women …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL